Exchange: NASDAQ·Updated 07:30 PM EDT
PHAT logo

PHAT Phathom Pharmaceuticals Inc

$9.23
$0.21
(2.27%)
Today
Closed $9.05
$0.18
(1.99%)
After Hours
EarningsOct 29
Mkt Cap$749.14M
Vol663,058.00

About PHAT

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.
33

Bearish Sentiment

How do you feel about PHAT?

Advertisement|Remove ads.